The short explanation
This is reassuring news. 'Benign' means no cancer was found in the samples. 'Concordant' means the biopsy result matches what the imaging showed, so the doctors are confident the samples came from the right area and explain what was seen on the scan. When both are true, the usual advice is to return to routine screening, as your doctor said. Being able to stop worrying about this finding is fair. It still makes sense to keep up breast awareness and routine screening, because any new change in future is a separate matter.
What depends on your situation
The parts of this that change from woman to woman. Uncertainty is stated, not hidden.
- If the biopsy had been 'discordant', meaning the result did not match the scan, more tests or surgery would usually be suggested. Your doctor has told you that is not the case.
- Some benign findings, such as certain cell changes called atypia, are linked to a higher future risk and change follow-up. Ask whether your report mentions anything like this.
- Keep a copy of the biopsy and imaging reports. They are useful for comparison at future mammograms.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot interpret your full report. Your doctor, who has read it in detail, is the right person to explain it.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Does my report mention any findings that change my future risk?
- When should my next routine mammogram be?
- Will a marker clip show up on future scans?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Book an appointment soon
- See a clinician within a couple of weeks if you notice a new lump or change in the breast.
Raise it at a routine appointment
- Return to routine screening as advised, and keep your reports together.
Sources
The evidence this explanation is built on.
- Mammography MedlinePlus (NIH)
- Mammograms National Cancer Institute (NIH)
- Breast cancer MedlinePlus (NIH)
Who wrote and reviewed this
Every AskHer answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHer Editorial (AI-assisted draft) AskHer's editorial team — not an individual clinician Works in English, தமிழ், हिन्दी
- Clinical reviewer
- Nobody yet No clinician has signed this answer off, and no person on the editorial team has read it yet. That is what the “Written with AI assistance” label means. It is queued for an editor to read, and then for a clinician who works in this area. The sources it was drafted against are listed above.
- Review status
- Written with AI assistance — not yet reviewed by a person
- Last reviewed
- Not yet reviewed by a person
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks you which part was hard to follow, so the author knows what to rewrite. “My question is different” opens a private follow-up with this answer attached.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.